78 related articles for article (PubMed ID: 18593345)
1. Profiling resistance-related mutations in the protease region of the pol gene: single genome sequencing of HIV in plasma and peripheral blood mononuclear cells.
Guimarães AP; Sa-Filho DJ; Sucupira MC; Janini LM; Diaz RS
AIDS Res Hum Retroviruses; 2008 Jul; 24(7):969-71. PubMed ID: 18593345
[TBL] [Abstract][Full Text] [Related]
2. A 6-base pair insertion in the protease gene of HIV type 1 detected in a protease inhibitor-naive patient is not associated with indinavir treatment failure.
Stürmer M; Staszewski S; Doerr HW; Hertogs K
AIDS Res Hum Retroviruses; 2003 Nov; 19(11):967-8. PubMed ID: 14678603
[TBL] [Abstract][Full Text] [Related]
3. Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART.
Chew CB; Potter SJ; Wang B; Wang YM; Shaw CO; Dwyer DE; Saksena NK
J Clin Virol; 2005 Jul; 33(3):206-16. PubMed ID: 15911442
[TBL] [Abstract][Full Text] [Related]
4. Indinavir plasma concentrations and resistance mutations in patients experiencing early virological failure.
González de Requena D; Gallego O; de Mendoza C; Corral A; Jiménez-Nácher I; Soriano V
AIDS Res Hum Retroviruses; 2003 Jun; 19(6):457-9. PubMed ID: 12882654
[TBL] [Abstract][Full Text] [Related]
5. Emergence of protease inhibitor resistance-associated mutations in plasma HIV-1 precedes that in proviruses of peripheral blood mononuclear cells by more than a year.
Bi X; Gatanaga H; Ida S; Tsuchiya K; Matsuoka-Aizawa S; Kimura S; Oka S
J Acquir Immune Defic Syndr; 2003 Sep; 34(1):1-6. PubMed ID: 14501787
[TBL] [Abstract][Full Text] [Related]
6. Genotypic resistance analyses in nucleoside-pretreated patients failing an indinavir containing regimen: results from a randomized comparative trial: (Novavir ANRS 073).
Descamps D; Joly V; Flandre P; Peytavin G; Meiffrédy V; Delarue S; Lastère S; Aboulker JP; Yeni P; Brun-Vézinet F
J Clin Virol; 2005 Jun; 33(2):99-103. PubMed ID: 15911424
[TBL] [Abstract][Full Text] [Related]
7. Analysis of HIV-1 drug-resistant variants in plasma and peripheral blood mononuclear cells from untreated individuals: implications for clinical management.
Bon I; Alessandrini F; Borderi M; Gorini R; Re MC
New Microbiol; 2007 Jul; 30(3):313-7. PubMed ID: 17802917
[TBL] [Abstract][Full Text] [Related]
8. Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy.
Servais J; Lambert C; Fontaine E; Plesséria JM; Robert I; Arendt V; Staub T; Schneider F; Hemmer R; Burtonboy G; Schmit JC
J Clin Microbiol; 2001 Feb; 39(2):454-9. PubMed ID: 11158089
[TBL] [Abstract][Full Text] [Related]
9. Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy.
Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Niubó J; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
Antivir Ther; 2012; 17(3):577-83. PubMed ID: 22301439
[TBL] [Abstract][Full Text] [Related]
10. Associations between amino acids in the evolution of HIV type 1 protease sequences under indinavir therapy.
Brown AJ; Korber BT; Condra JH
AIDS Res Hum Retroviruses; 1999 Feb; 15(3):247-53. PubMed ID: 10052755
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the protease sequences of HIV-1 infected individuals after Indinavir monotherapy.
Sa-Filho DJ; Costa LJ; de Oliveira CF; Guimarães AP; Accetturi CA; Tanuri A; Diaz RS
J Clin Virol; 2003 Oct; 28(2):186-202. PubMed ID: 12957189
[TBL] [Abstract][Full Text] [Related]
12. Drug-resistant variants that evolve during nonsuppressive therapy persist in HIV-1-infected peripheral blood mononuclear cells after long-term highly active antiretroviral therapy.
Verhofstede C; Noë A; Demecheleer E; De Cabooter N; Van Wanzeele F; Van Der Gucht B; Vogelaers D; Plum J
J Acquir Immune Defic Syndr; 2004 Apr; 35(5):473-83. PubMed ID: 15021312
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
[TBL] [Abstract][Full Text] [Related]
14. Highly diversified multiply drug-resistant HIV-1 quasispecies in PBMCs: a case report.
Quan Y; Brenner BG; Dascal A; Wainberg MA
Retrovirology; 2008 May; 5():43. PubMed ID: 18513421
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure.
Sangeda RZ; Theys K; Beheydt G; Rhee SY; Deforche K; Vercauteren J; Libin P; Imbrechts S; Grossman Z; Camacho RJ; Van Laethem K; Pironti A; Zazzi M; Sönnerborg A; Incardona F; De Luca A; Torti C; Ruiz L; Van de Vijver DA; Shafer RW; Bruzzone B; Van Wijngaerden E; Vandamme AM;
Infect Genet Evol; 2013 Oct; 19():349-60. PubMed ID: 23523594
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 population bottleneck during indinavir therapy causes a genetic drift in the env quasispecies.
Ibáñez A; Clotet B; Martínez MA
J Gen Virol; 2000 Jan; 81(Pt 1):85-95. PubMed ID: 10640545
[TBL] [Abstract][Full Text] [Related]
17. Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir.
Vergani B; Cicero ML; Vigano' O; Sirianni F; Ferramosca S; Vitiello P; Di Vincenzo P; Pia De Pasquale M; Galli M; Rusconi S
J Clin Virol; 2008 Feb; 41(2):154-9. PubMed ID: 18024202
[TBL] [Abstract][Full Text] [Related]
18. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
[TBL] [Abstract][Full Text] [Related]
19. Phylogeny and resistance profiles of HIV-1 POL sequences from rectal biopsies and blood.
Katzenstein TL; Petersen AB; Storgaard M; Obel N; Jensen-Fangel S; Nielsen C; Jørgensen LB
J Med Virol; 2010 Jul; 82(7):1103-9. PubMed ID: 20513071
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir.
Côté HC; Brumme ZL; Harrigan PR
J Virol; 2001 Jan; 75(2):589-94. PubMed ID: 11134271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
